Medical News

RSS

Covidien introduces Endo GIA Radial Reload with Tri-Staple technology for LAR procedures

Covidien, a leading global provider of healthcare products, today announced the launch of the Endo GIA Radial Reload with Tri-Staple technology.

1 Jun 2012

Cleveland Clinic, Cadence Health expand relationship for cardiology services

Cadence Health, the health system created through the merger of Central DuPage Health and Delnor Community Health System, announced an expansion of its relationship with the Cleveland Clinic to include cardiology services.

1 Jun 2012

ForteBio introduces new biosensor for use on Octet and BLItz instrumentation platforms

ForteBio, a division of Pall Life Sciences and a leading supplier of label-free technology that accelerates the development of biotherapeutic and pharmaceutical products, today announced the introduction of its Dip and Read Ni-NTA biosensor for use on its Octet and BLItz instrumentation platforms.

1 Jun 2012

Oncothyreon commences PX-866 and vemurafenib Phase 1/2 combination trial for melanoma

Oncothyreon Inc. today announced the initiation of a Phase 1/2 trial of PX-866 in combination with vemurafenib.

1 Jun 2012

New MYiCLUBonline iPhone/iPad App from ABC Financial

ABC Financial, the leading software and payment processing provider to the health and fitness industry, announced today the release of their new MYiCLUBonline iPhone/iPad App.

1 Jun 2012

Researchers develop special brassiere for breast cancer patients

In cooperation with Amoena Medizin-Orthopädie-Technik GmbH, researchers from the Hohenstein Institute have taken on a highly sensitive yet very important issue. In the framework of the publicly funded research project they developed a special brassiere for breast cancer patients.

1 Jun 2012

RXi’s RXI-109 IND receives FDA clearance to proceed into clinical trials

RXi Pharmaceuticals Corporation today announced that it has received clearance for its investigational new drug application (IND) from the U.S. Food and Drug Administration (FDA) to initiate clinical trials with RXI-109, a self-delivering RNAi compound that selectively targets Connective Tissue Growth Factor.

1 Jun 2012

Aspirin controls two key processes to kill bowel cancer cells

Aspirin kills cancer cells by controlling two key processes that influence energy use in cells and could explain how aspirin can prevent bowel cancer. The research is published in this month's Gastroenterology.

1 Jun 2012

IL-6 protein plays a pivotal role in the duration of acute pancreatitis

Scientists from the Universities of Illinois and California have found that the inflammatory protein interleukin-6 (IL-6) plays a pivotal role in the duration of acute pancreatitis in animal models with this condition.

1 Jun 2012

Ventas agrees to sell 5,200,000 shares of common stock to Citigroup

Ventas, Inc. announced today that it has agreed to sell 5,200,000 shares of its common stock to Citigroup, as sole underwriter, in an underwritten public offering.

1 Jun 2012

Omeros commences planned PK substudy in Phase 3 clinical program of OMS302

Omeros Corporation today announced the initiation of the planned pharmacokinetic (PK) substudy in its Phase 3 clinical program evaluating OMS302 in patients undergoing intraocular lens replacement (ILR) surgery.

1 Jun 2012

suPAR protein can serve as marker for blood poisoning

Blood poisoning is a serious problem in medical care. Research from Malmö University in Sweden now shows that the protein suPAR, which can be used for early detection of critical cases of sepsis, is found in saliva, which opens new potential for tracking diseases.

1 Jun 2012

Verinata Health to present two key studies on verifi prenatal test at ISPD conference

Verinata Health, Inc., a privately-held company dedicated to maternal and fetal health, today announced that physicians across the country are now using the verifi prenatal test.

1 Jun 2012

FDA approves RBI’s AppliGel-G for human testing

Royer Biomedical, Inc. (RBI) received FDA approval to proceed with Human Testing of AppliGel-G (Gentamicin) in management of Diabetic Foot Ulcers.

1 Jun 2012

State roundup: Federal judge rejects Calif. request to end oversight of prison health care; States push prescription drug databases; Medicare drug benefit at issue in Utah Senate race

A federal judge rejected a request by California prison officials Wednesday to regain control of inmate health care, which has been under court-supervised receivership for six years, and said the state must first show it can provide adequate medical treatment. ... The current receiver, Clark Kelso, has reported improvements in the prisons' medical staff and facilities, and said a "turnaround plan" he proposed for the system in 2008 is about 80 percent complete.

1 Jun 2012

Betel quid popularity in Chinese prompts health warning

The use of betel quid, a mixture of betel leaf, areca nut, and slaked lime, is used by one in six adults in mainland China, a survey has found.

31 May 2012

Noncommunicable diseases need more attention among prisoners

Prisons are not taking appropriate action to improve diet and increase physical activity levels to help prevent noncommunicable diseases among prisoners, say UK researchers in The Lancet.

31 May 2012

Fall prevention needed in multiple sclerosis patients

Patients with multiple sclerosis are at increased risk for fractures, particularly those related to falls, a study shows.

31 May 2012

Common pain killers linked to decreased skin cancer risk

Use of nonsteroidal anti-inflammatory drugs is associated with a decreased risk for skin cancer, particularly squamous cell carcinoma and malignant melanoma, study findings indicate.

31 May 2012

Thrombosis biomarker levels differ according to thrombolysis strategy

An early invasive strategy following thrombolysis for ST-segment-elevation myocardial infarction is associated with significant changes in the levels of inflammatory and thrombotic biomarkers, a substudy of the Norwegian study on district treatment of STEMI shows.

31 May 2012